0001179110-11-013440.txt : 20110920
0001179110-11-013440.hdr.sgml : 20110920
20110920203534
ACCESSION NUMBER: 0001179110-11-013440
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110916
FILED AS OF DATE: 20110920
DATE AS OF CHANGE: 20110920
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Buckland Martin
CENTRAL INDEX KEY: 0001525784
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-27628
FILM NUMBER: 111100428
MAIL ADDRESS:
STREET 1: 436 CAMBRIDGE SCIENCE PARK
STREET 2: MILTON ROAD
CITY: CAMBRIDGE
STATE: X0
ZIP: CB40QA
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Astex Pharmaceuticals, Inc
CENTRAL INDEX KEY: 0000919722
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 911841574
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4140 DUBLIN BLVD
STREET 2: SUITE 200
CITY: DUBLIN
STATE: CA
ZIP: 94568
BUSINESS PHONE: 9255600100
MAIL ADDRESS:
STREET 1: 4140 DUBLIN BLVD
STREET 2: STE 200
CITY: DUBLIN
STATE: CA
ZIP: 94568
FORMER COMPANY:
FORMER CONFORMED NAME: SUPERGEN INC
DATE OF NAME CHANGE: 19960125
4
1
edgar.xml
FORM 4 -
X0304
4
2011-09-16
0
0000919722
Astex Pharmaceuticals, Inc
ASTX
0001525784
Buckland Martin
C/O ASTEX PHARMACEUTICALS
436 CAMBRIDGE SCIENCE PARK MILTON ROAD
CAMBRIDGE
X0
CB4 0QA
UNITED KINGDOM
0
1
0
0
Chief Business Officer
Employee Stock Option (Right to buy)
2.21
2011-09-16
4
A
0
150000
0
A
2021-09-16
Common Stock
150000
150000
D
Grant to reporting person of option to buy 150,000 shares of common stock under the Issuer's 2003 Stock Plan. The option vests and becomes exercisable as to 1/4th of the shares on September 16, 2012 and as to 1/48th of the shares on each one month anniversary thereafter.
/s/ Martin Buckland
2011-09-20